9197. β2-microglobulin
Description
β2-microglobulin – a protein synthesized in almost all cells of the body, ensures the functioning of cellular immunity.
The test is used to determine the prognosis, control treatment and the risk of recurrence of oncological diseases (multiple myeloma, some forms of leukemia and lymphoma), assess the functional activity of the kidneys (after kidney transplantation, systemic diseases (rheumatoid arthritis, scleroderma, etc.)).
It should be taken in combination with specific oncomarkers, general and biochemical blood tests.
When and who needs the test?
In oncology:
- prognosis and effectiveness of treatment of myeloid disease, B-lymphomas, chronic lymphocytic leukemia;
- in combination with other tumor markers in gastrointestinal cancers;
- in HIV-infected patients, assessing the activity of the disease, monitoring the effectiveness of treatment;
- in nephrology: a marker of kidney function, differential diagnosis of glomerular and tubular lesions, monitoring the effectiveness of dialysis (before and after dialysis);
- assessment of drug nephrotoxicity; monitoring of rejection after transplantation;
- systemic diseases: assessment of the activity and condition of the kidneys in RA, SLE, and other diseases.
Biological material
- Venous blood
Preparing for a blood test
In order to exclude factors that may affect the test results, we recommend to follow the preparation rules:
- an important condition for laboratory tests is to take blood on an empty stomach.
- 6-12 hours before the test, you should avoid eating, drinking alcohol, smoking, and limit physical activity. Drinking...